Revelation Capital Management 13F annual report
Revelation Capital Management is an investment fund managing more than $4.26 million ran by Michael Boggs. There are currently 3 companies in Mr. Boggs’s portfolio. The largest investments include Singular Genomics Systems Inc and Akili Inc, together worth $4.1 million.
$4.26 million Assets Under Management (AUM)
As of 31st October 2022, Revelation Capital Management’s top holding is 1,415,846 shares of Singular Genomics Systems Inc currently worth over $3.54 million and making up 83.2% of the portfolio value.
In addition, the fund holds 245,912 shares of Akili Inc worth $556 thousand.
The third-largest holding is Neuropace Inc worth $161 thousand.
Currently, Revelation Capital Management's portfolio is worth at least $4.26 million. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
Careers at Revelation Capital Management
The Revelation Capital Management office and employees reside in Sausalito, California. According to the last 13-F report filed with the SEC, Michael Boggs serves as the Managing Member at Revelation Capital Management.
Recent trades
In the most recent 13F filing, Revelation Capital Management revealed that it had opened a new position in
Akili Inc and bought 245,912 shares worth $556 thousand.
On the other hand, there are companies that Revelation Capital Management is getting rid of from its portfolio.
Revelation Capital Management closed its position in Accolade on 7th November 2022.
It sold the previously owned 58,050 shares for $430 thousand.
Michael Boggs also disclosed a decreased stake in Neuropace Inc by 0.8%.
This leaves the value of the investment at $161 thousand and 42,972 shares.
One of the smallest hedge funds
The two most similar investment funds to Revelation Capital Management are Newfleet Asset Management and Crescendo Partners Ii, L.P.. They manage $4.27 million and $4.19 million respectively.
The complete list of Revelation Capital Management trades based on 13F SEC filings
These positions were updated on November 7th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Singular Genomics Systems Inc |
No change
1,415,846
|
$3,540,000 | 83.16% |
| Akili Inc |
Opened
245,912
|
$556,000 | 13.06% |
| Accolade, Inc. |
Closed
58,050
|
$430,000 | |
| Neuropace Inc |
82.68%
42,972
|
$161,000 | 3.78% |
| No transactions found | |||
| Showing first 500 out of 4 holdings | |||
Hedge funds similar to Revelation Capital Management
- Strategic Investment Opportunities
- Tradelink Capital
- Mohican Management
- Schutz Anton Villars
- Amia Capital LL.P.
- Candlewood Investment L.P.
- Newfleet Asset Management
- Crescendo Partners Ii, L.P.
- Vitol Sarl
- Susquehanna Foundation
- Inspire Developers
- Baymount Management L.P.
- Delaware Management Business Trust
- Healthcor Partners Management L.P.